<DOC>
	<DOC>NCT02640391</DOC>
	<brief_summary>The purpose of this study is to determine whether fecal calprotectin, fecal immunochemical test, and Rome III criteria for irritable bowel syndrome (IBS) can predict mucosal healing in patients with quiescent ulcerative colitis (UC).</brief_summary>
	<brief_title>Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients with ulcerative colitis who have no change of medication for at least 6 months Patients with ulcerative colitis who are in remission (Mayo score &lt;3) Patients with ulcerative colitis who will undergo colonoscopy for surveillance or mucosal healing checkup Patients who refuse to participate Patients who have a history of colectomy Patients who have instinal stricture or perforation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>fecal calprotectin</keyword>
	<keyword>mucosal healing</keyword>
</DOC>